AdvaMed Congratulates Dr. Stephen Hahn on Nomination as FDA Commissioner

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement today from President and CEO Scott Whitaker regarding President Trump’s nomination of Dr. Stephen Hahn to serve as FDA Commissioner: 

“We congratulate Dr. Hahn on his nomination to lead FDA, and we hope the Senate moves swiftly to confirm him. Dr. Hahn’s distinguished career as a health care provider and researcher gives him a unique perspective on the importance of patient access to the latest medical advances. His extensive management experience and evidence-based approach to addressing the significant health care challenges we face today will serve him well in his new post. We look forward to working with him on behalf of the patients our industry serves.”